Abstract: A thermoplastic polyurethane is a reaction product obtained from components including (A) an aliphatic polyisocyanate, (B) an aliphatic polyol having at least one side chain, and (C) chain extenders. The aliphatic polyol (B) is a polycarbonate diol of formula (I): In formula (I), n is 4 to 40, and n+1 Rs are composed of a linear alkylene and an alkylene having at least one side chain so as to have the molar ratio of the linear alkylene to the alkylene having at least one side chain in the range of 0:100 to 95:5. The chain extender (C) is a combination of 1,4-butanediol with 1,3-propanediol, 1,5-pentanediol, 3-methyl-1,5-pentanediol, or ethylene glycol, and the amount of 1,4-butanediol is 50% by mass or more based on the total amount of the chain extenders (C). A resin composition containing the thermoplastic polyurethane and a corresponding molded product are also provided.

Abstract: A method is described for debonding a bonded article. The bonded article comprises at least two components which are bonded to one another by means of a polyurethane adhesive selected from aqueous polyurethane dispersion adhesives and polyurethane hotmelt adhesives. At least one of the components is a thermoplastic polyurethane. The components are debonded by treatment with an aqueous surfactant composition at elevated temperatures.

Abstract: The present invention relates to chemical compounds which can be used in particular as structural mimetics of proline-rich peptides. The compounds of the present invention are capable of selectively inhibiting Ena/VASP-EVH1-mediated protein-protein interactions. The invention further relates to the use of these compounds as pharmaceutical agents and the use of the pharmaceutical agents for the treatment of tumor diseases.